Developer of intimate skin patch designed to assist in the treatment of premature ejaculation. The company's products treat male sexual dysfunction using an intimate skin patch with neuromodulation capabilities, enabling patients to delay the onset of the premature phase of ejaculation.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC | 08-Feb-2021 | 00.000 | In Progress | Generating Revenue | ||
3. Angel (individual) | 28-Feb-2020 | 00000 | 00.000 | Completed | Generating Revenue | |
2. Early Stage VC | 17-Oct-2017 | $854K | $854K | 00.00 | Completed | Startup |
1. Early Stage VC | Completed | Startup |
Name | Representing | Role | Since |
---|---|---|---|
Oded Kraft | Virility Medical | Director & Board Member | 000 0000 |
Ron Mayron | Self | Chairman | 000 0000 |
Ron Zuckerman | Virility Medical | Board Member | 000 0000 |
Tal Gollan | Virility Medical | Founder, Chief Technology Officer & Board Member | 000 0000 |
Zohar Gendler | Virility Medical | Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Next Generation Technology | Venture Capital | Minority | 000 0000 | 000000 0 | |
Almeda Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Arkin Holdings | PE/Buyout | Minority | 000 0000 | 000000 0 |